Towards the development of new anti cancer agents targeting the serine synthetic pathway (Spillier, Quentin;Ravez, Séverine;Corbet, Cyril;Feron, Olivier;Frédérick, Raphaël(2018) BACR Meeting — Location: Liège, Belgium (27.January.2018)
FilesUnpublishedabstract.pdf Open Access Adobe PDF34.43 KBDownloadDetailsAuthorsSpillier, QuentinUCLouvainAuthorRavez, SéverineUCLouvainAuthorCorbet, CyrilUCLouvainAuthorFeron, OlivierUCLouvainAuthorFrédérick, RaphaëlUCLouvainAuthorAffiliationsUCLouvainSSS/LDRI - Louvain Drug Research InstituteUCLouvainSSS/IREC/FATH - Pôle de Pharmacologie et thérapeutiqueShow moreCitations APA Chicago FWB Spillier, Q., Ravez, S., Corbet, C., Feron, O., & Frédérick, R. (2018). Towards the development of new anti cancer agents targeting the serine synthetic pathway (. BACR Meeting, Liège, Belgium. https://hdl.handle.net/2078.5/216373